RCM
EPZM

RA Capital Management’s Epizyme, Inc EPZM Stock Holding History

RA Capital Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-227,092
Closed -$2.92M – 52
2015
Q3 		$2.92M Buy
+227,092
New +$4.58M 0.42% 39
2013
Q4 		– Sell
-10,000
Closed -$400K – 42
2013
Q3 		$400K Sell
10,000
-141,000
-93% -$4.77M 0.04% 38
2013
Q2 		$4.25M Buy
+151,000
New +$3.88M 0.56% 26

Other funds holding EPZM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RA Capital Management's EPZM Position: Q4 2015 in Review

RA Capital Management sold out of Epizyme, Inc (EPZM) in Q4 2015, closing a stake of 227,092 shares — an estimated $2.92M sold.

RA Capital Management first reported a position in EPZM in Q2 2013 and held it in 3 quarters. The position peaked at $4.25M in Q2 2013. 89 funds tracked by Wall St. Rank hold EPZM as of Q4 2015.

  • RA Capital Management reported no remaining Epizyme, Inc position as of Q4 2015 after selling out during the quarter.
  • RA Capital Management sold 227,092 Epizyme, Inc shares in Q4 2015, an estimated $2.92M.
  • RA Capital Management first reported a position in Epizyme, Inc in Q2 2013 and held it in 3 quarters.
  • RA Capital Management's Epizyme, Inc position peaked at $4.25M in Q2 2013.
  • 89 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2015.

Based on RA Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.